The quick read
Latest quote·Oct 9
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Vicore Pharma Holding AB American Depositary Shares (VCRE) insiders filed no open-market purchases or sales in the 90 days to Oct 14, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a VCRE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
No tracked top-trader positions in VCRE right now.
Live Hyperliquid positioning - not every stock is covered
No earnings history.
This company is running thin margins.
Valuation
Quality
Growth
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace